Life Science Lab Feasibility Study in California

California research businesses: first in the nation

California ranks 1 of 41 states for life science research loans, and that rank is the first fact worth knowing. The FY2017 to FY2026 record holds 57 life science research approvals worth $56.5 million. Still, the class sits 28 of 39 among California industries and carries a location quotient of 1.33x, so the lender interest is a feature of the national pattern, with California simply the biggest piece of it. The $500,000 median is 2.00x the nationwide median, and that doubling is the measure that clears the margin.

At least 20.5% of California life science research approvals through FY2024 were cancelled, and with no undisbursed loans to add, the ceiling is identical. That is a high floor, and a lender should read it as evidence of how often research ventures change plans before closing: funding rounds slip, leases fall through and equipment orders change. For a sponsor, an approval is not a closing.

Wide range of sizes, mixed programs

The central half of loans runs from $155,000 to $1.5 million. Under 7(a) there are 36 loans and under 504 there are 21, a high real estate share for a research business, and franchising is 0.00%. The Mortgage Capital Development Corporation has 10 loans and $19.0 million. Newtek Bank, National Association has 10 loans but $7.4 million, California Statewide Certified Development Corporation has 6 loans and $13.6 million, while Wells Fargo Bank National Association shows 5 loans worth only $70,000, evidently small facilities or lines.

San Diego County has 15 loans, Los Angeles 12 and Orange 9, then Alameda 4 and Santa Clara 3. The southern cluster is far larger than the Bay Area. Counts peaked at 12 in FY2025 and 11 in FY2024, with FY2026 showing 1 loan for $20,000. California's charge-off rate stays off the page, as the disbursed group is thin, and no one should take that as a clean record.

Diligence for a California lab

A study must separate wet lab space from office, since build-out cost, ventilation, power and hazardous waste handling differ sharply. Demand means tenants or the owner's own research revenue, and funding stage matters. Coverage cannot rest on a grant or a financing round that has not closed. The appraisal should test reuse value, because a specialized lab sells to a narrow pool. One caution: the category is the research business and not the building, and the code also holds research outside life science.